21世纪传媒 · 公众号矩阵成员。 记者丨 韩利明 实习生蒋雨桐 编辑丨季媛媛 曾静娇 张伟贤 日前，有媒体报道称，爱尔眼科（300015.SZ）正在考虑赴港IPO上市。对此，21世纪经济报道记者致电爱尔 眼科方面，相关工作人员表示 "相关事宜请以公司官方公告为准"，未对此事做进一步解释。 赴港上市传闻背后，这家民营眼科连锁巨头正面临较为严峻的发展考验。资本市场层面，2009年，爱尔眼科 以28元/股的发行价登陆深交所创业板，2021年股价一度涨超41元/股（前复权）。随后，爱尔眼科股价震荡 下跌， 当前徘徊在10元/股附近，较峰值跌去超七成， 到如今市值蒸发超2500亿元，目前 缩水至1000亿元左 右。 业绩表现上， 爱尔眼科营收增速已连续多年呈现下滑态势。 数据显示，2024年营业收入同比仅增长3.02%， 较2023年26.43%的同比增速大幅放缓；同期归母净利润同比增长5.87%，同样低于2023年33.07%的增速。进 入2025年，业绩压力进一步凸显。 以下文章来源于21新健康 ，作者韩利明，蒋雨桐 21新健康 . 与此同时，爱尔眼科旗下医院频繁出现的违规处罚及医疗纠纷，正侵蚀公司的品牌声誉与公 ...

Summary of Key Points Core Viewpoint The company, Opcon Vision Technology Co., Ltd., is changing part of its fundraising purpose to acquire a 75% stake in Suqian Shangyue Qicheng Hospital Management Co., Ltd. This strategic move aims to enhance operational efficiency and align with the company's long-term development goals. Group 1: Fundraising and Financial Overview - The actual amount raised from the stock issuance was RMB 149,406.89 million after deducting issuance costs, with funds received in June 2022 [2][3]. - As of December 31, 2024, the company has utilized RMB 39,677.38 million of the raised funds, with a remaining balance of RMB 12,726.07 million after accounting for interest and investment income [3][4]. - The company plans to redirect RMB 23,373.00 million from the "Community Optical Service Terminal Construction Project" to fund the acquisition of Shangyue Qicheng [4][5]. Group 2: Acquisition Details - The total investment for acquiring a 75% stake in Shangyue Qicheng is RMB 33,390.00 million, with RMB 23,373.00 million sourced from the raised funds and RMB 10,017.00 million from the company's own funds [5][9]. - The acquisition aligns with the company's dual-driven development strategy of "full optical products + all-age optical services," enhancing its market presence in Yunnan Province [7][8]. - Shangyue Qicheng has established a comprehensive operational system and possesses strong brand recognition and profitability potential in the region [7][12]. Group 3: Financial Performance and Projections - Shangyue Qicheng's audited financial data shows total assets of RMB 11,073.59 million and net assets of RMB 6,151.34 million as of the latest report [14]. - The company has committed to achieving specific net profit targets from 2025 to 2029, with a minimum of RMB 3,900 million in 2025 [24]. - Future revenue growth is projected based on the expansion of service offerings and market penetration strategies, with a focus on medical services and optical products [21][22].